Frank S Lieberman

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.

Susan M. Chang, M. Gilbert, M. Mehta, 2020, Neuro-oncology.

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

Timothy F Cloughesy, Mark R Gilbert, Patrick Y Wen, 2008, Neuro-oncology.

NABTC phase I/II trial of ZD-1839 for recurrent malignant gliomas and unresectable meningiomas.

M. Prados, F. Lieberman, P. Wen, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma

R. Strowd, M. Ahluwalia, S. Desideri, 2023, Journal of Neuro-Oncology.

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

T. Mikkelsen, K. Aldape, M. Prados, 2015, Neuro-oncology.